Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma (original) (raw)

References

  1. National Cancer Institute D. Surveillance research programe, cancer statistics branch. SEER program public-use data. Available at: http://seer.cancer.gov, 2003.
  2. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ . Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5–26.
    Article Google Scholar
  3. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987–994.
  4. Jones SE, Fuks Z, Bull M, Kadin ME, Dorfman RF, Kaplan HS et al. Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer 1973; 31: 806–823.
    Article CAS Google Scholar
  5. Carbone A, Volpe R, Gloghini A, Trovo M, Zagonel V, Tirelli U et al. Non-Hodgkin's lymphoma in the elderly. I. Pathologic features at presentation. Cancer 1990; 66: 1991–1994.
    Article CAS Google Scholar
  6. Barnes N, Cartwright RA, O'Brien C, Roberts B, Richards ID, Hopkinson JM et al. Variation in lymphoma incidence within Yorkshire Health Region. Br J Cancer 1987; 55: 81–84.
    Article CAS Google Scholar
  7. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235–242.
    Article CAS Google Scholar
  8. Velasquez WS, McLaughlin P, Tucker S, Hagemeister FB, Swan F, Rodriguez MA et al. ESHAP – an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol 1994; 12: 1169–1176.
    Article CAS Google Scholar
  9. Velasquez WS, Cabanillas F, Salvador P, McLaughlin P, Fridrik M, Tucker S et al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood 1988; 71: 117–122.
    CAS Google Scholar
  10. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540–1545.
    Article CAS Google Scholar
  11. Morris CL, Siegel E, Barlogie B, Cottler-Fox M, Lin P, Fassas A et al. Mobilization of CD34+ cells in elderly patients (>/=70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen. Br J Haematol 2003; 120: 413–423.
    Article Google Scholar
  12. Badros A, Barlogie B, Siegel E, Morris C, Desikan R, Zangari M et al. Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years. Br J Haematol 2001; 114: 600–607.
    Article CAS Google Scholar
  13. Stamatoullas A, Fruchart C, Khalfallah S, Buchonnet G, Contentin N, Bastit D et al. Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age. Bone Marrow Transplant 1997; 19: 31–35.
    Article CAS Google Scholar
  14. Moreau P, Milpied N, Voillat L, Colombat P, Mahe B, Rapp MJ et al. Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study. Bone Marrow Transplant 1998; 21: 1193–1196.
    Article CAS Google Scholar
  15. Jantunen E, Mahlamaki E, Nousiainen T . Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>/=60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol. Bone Marrow Transplant 2000; 26: 737–741.
    Article CAS Google Scholar
  16. Leger CS, Bredeson C, Kearns B, Bence-Bruckler I, Atkins H, Huebsch L . Autologous blood and marrow transplantation in patients 60 years and older. Biol Blood Marrow Transplant 2000; 6: 204–210.
    Article CAS Google Scholar
  17. Gopal AK, Gooley TA, Golden JB, Maloney DG, Bensinger WI, Petersdorf SH et al. Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older. Bone Marrow Transplant 2001; 27: 593–599.
    Article CAS Google Scholar
  18. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849.
    Article CAS Google Scholar
  19. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244.
    Article CAS Google Scholar
  20. Kaplan E, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
    Article Google Scholar
  21. Cox D . Regression models and life tables. J R Stat Soc 1972; 34: 187–220.
    Google Scholar
  22. Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002–1006.
    Article CAS Google Scholar
  23. Miller TP, Dana BW, Weick JK, Jones SE, Coltman CA, Dahlberg S et al. Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas. Semin Hematol 1988; 25: 17–22.
    CAS PubMed Google Scholar
  24. Armitage JO . Treatment of non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1023–1030.
    Article CAS Google Scholar
  25. Bitran JD, Klein L, Link D, Kosirog-Glowacki J, Stewart C, Raack D et al. High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphoma. Biol Blood Marrow Transplant 2003; 9: 383–388.
    Article Google Scholar
  26. Micallef IN, Lillington DM, Apostolidis J, Amess JA, Neat M, Matthews J et al. Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. J Clin Oncol 2000; 18: 947–955.
    Article CAS Google Scholar

Download references